Immunovaccine

Read more
Frederic Ors's photo - CEO of Immunovaccine

CEO

Frederic Ors

CEO Approval Rating

70/100

Founded:

06/2000

Status:

PublicIndependent CompanyTMX Group - Toronto Stock ExchangeIMV

Annual Revenue
$ < 1M
Employees
20
Sector

- -

Immunovaccine Quarterly and Annual Revenue

Coming soon for Immunovaccine!

Annual Revenue

$ < 1M

Immunovaccine Acquisitions

No recent acquisitions found related to Immunovaccine

Immunovaccine Funding History

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
May 2016
$8M
-

Immunovaccine Investments

No recent investments found related to Immunovaccine

Immunovaccine News

Immunovaccine Press Releases

Social Media

Immunovaccine Headquarters

1344 Summer Street Suite 412

Halifax, Nova ScotiaB3H 0A8

902-492-1819

Driving Directions »

Trending Companies

Immunovaccine Summary

ABOUT

Overview

Immunovaccine develops vaccines for cancer immunotherapies and infectious diseases. Immunovaccine was founded in 06/2000. Immunovaccine's headquarters is located in Halifax, Nova Scotia, CA B3H 0A8. It has raised 8.0M in 1 round. The latest round was ...

CEO

Immunovaccine's CEO, Frederic Ors, currently has an approval rating of 70%. Immunovaccine's primary competitors are

Frequently Asked Questions about Immunovaccine

  1. When was Immunovaccine founded?

    Immunovaccine was founded in 06/2000
  2. Who is Immunovaccine's CEO?

    Immunovaccine's CEO is Frederic Ors
  3. How much revenue does Immunovaccine generate?

    Immunovaccine generates $ < 1M in revenue
  1. How much funding does Immunovaccine have?

    Immunovaccine has historically raised $8M in funding
  2. Where is Immunovaccine's headquarters?

    Immunovaccine's headquarters is in Halifax Nova Scotia, CA
  3. How many employees does Immunovaccine have?

    Immunovaccine has 20 employees